Psychosocial interventions for pregnant women in outpatient illicit drug treatment programs compared to other interventions

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 4, 2015, Pages

  Terplan, Mishka ^a   Ramanadhan, Shaalini ^b   Locke, Abigail ^c   Longinaker, Nyaradzo ^d   Lui, Steve ^c  

^a Child and Adolescent Services   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF HUDDERSFIELD   (United Kingdom)

^d UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE;

CHILD CARE; CLINICAL EFFECTIVENESS; CONTINGENCY MANAGEMENT; HEALTH PROGRAM; HOSPITALIZATION; HUMAN; ILLICIT DRUG TREATMENT PROGRAM; INTERMETHOD COMPARISON; LOW BIRTH WEIGHT; MATERNAL DISEASE; MATERNAL DRUG ABSTINENCE; MOTIVATIONAL INTERVIEWING; NEONATAL ABSTINENCE SYNDROME; NEONATAL OUTCOME; PARAMETERS CONCERNING THE FETUS, NEWBORN AND PREGNANCY; PATIENT COUNSELING; PATIENT EDUCATION; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PRENATAL CARE; PRIORITY JOURNAL; PROTOCOL COMPLIANCE; PSYCHOSOCIAL CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEXUALLY TRANSMITTED DISEASE; SYSTEMATIC REVIEW; THERAPY EFFECT; TRAFFIC AND TRANSPORT; WITHDRAWAL SYNDROME; FEMALE; LENGTH OF STAY; META ANALYSIS; NEWBORN; PATIENT DROPOUTS; PREGNANCY; PREGNANCY COMPLICATIONS; PREMATURE BIRTH; PSYCHOLOGY; PSYCHOTHERAPY; REINFORCEMENT; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS;

FEMALE; HUMANS; INFANT, NEWBORN; LENGTH OF STAY; PATIENT DROPOUTS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANT WOMEN; PREMATURE BIRTH; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REINFORCEMENT (PSYCHOLOGY); SUBSTANCE-RELATED DISORDERS;

EID: 84942437946     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006037.pub3     Document Type: Review

References (101)

1. Carroll KM, Chang G, Behr H, Clinton B, Kosten TR. Improving treatment outcome in pregnant, methadone-maintained women: Results from a randomized controlled trial. American Journal on Addictions 1995;4(1):56-9.
2. Elk R, Mangus L, Rhoades H, Andres R, Grabowski J. Cessation of cocaine use during pregnancy: effects of contingency management interventions on maintaining abstinence and complying with prenatal care. Addictive Behaviors 1998;23(1):57-64.
3. Haug NA, Svikis DS, DiClemente C. Motivational enhancement therapy for nicotine dependence in methadone-maintained pregnant women. Psychology of Addictive Behaviors 2004;18(3):289-92.
4. Jones HE, Haug NA, Stitzer ML, Svikis DS. Improving treatment outcomes for pregnant drug-dependent women using low-magnitude voucher incentives. Addictive Behaviors 2000;25(2):263-7.
5. Jones HE, Haug N, Silverman K, Stitzer M, Svikis D. The effectiveness of incentives in enhancing treatment attendance and drug abstinence in methadone-maintained pregnant women. Drug and Alcohol Dependence 2001;61(3):297-306.
6. Jones HE, O'Grady KE, Tuten M. Reinforcement-based treatment improves the maternal treatment and neonatal outcomes of pregnant patients enrolled in comprehensive care treatment. American Journal on Addictions 2011;20(3):196-204.
7. Mullins SM, Suarez M, Ondersman SJ, Page MC. The impact of motivational interviewing on substance abuse treatment retention: a randomised control trial of women involved with child welfare. Journal of Substance Abuse Treatment 2004;27(1):51-8.
8. O'Neill K, Baker A, Cooke M, Collins E, Heather N, Wodak A. Evaluation of a cognitive-behavioural intervention for pregnant injecting drug users at risk of HIV infection. Addiction 1996;91(8):1115-25.
9. Silverman K, Svikis D, Robles E, Stitzer ML, Bigelow GE. A reinforcement-based therapeutic workplace for the treatment of drug abuse: six-month abstinence outcomes. Experimental and Clinical Psychopharmacology 2001;9(1):14-23.
10. Svikis D, Lee JH, Haug NA, Stitzer ML. Attendance incentives for outpatient treatment: effects in methadone- and non methadone-maintained pregnant drug dependent women. Drug and Alcohol Dependence 1997;48(1):33-41.
11. Svikis D, Silverman K, Haug NA, Stitzer M, Keyser-Marcus L. Behavioral strategies to improve treatment participation and retention by pregnant drug-dependent women. Substance Use & Misuse 2007;42(10):1527-35.
12. Tuten M, Svikis DS, Keyser-Marcus L, O'Grady KE, Jones HE. Lessons learned from a randomized trial of fixed and escalating contingency management schedules in opioid-dependent pregnant women. American Journal of Drug and Alcohol Abuse 2012;38(4):286-92.
13. Winhusen T, Kropp F, Babcock D, Hague D, Erickson SJ, Renz C, et al. Motivational enhancement therapy to improve treatment utilization and outcome in pregnant substance users. Journal of Substance Abuse Treatment 2008;35(2):161-73.
14. Yonkers KA, Forray A, Howell HB, Gotman N, Kershaw T, Rounsaville BJ, et al. Motivational enhancement therapy coupled with cognitive behavioral therapy versus brief advice: a randomized trial for treatment of hazardous substance use in pregnancy and after delivery. General Hospital Psychiatry 2012;34(5):439-49.
15. Amato L, Minozzi S, Davoli M, Vecchi S, Ferri M, Mayet S. Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD005031]
16. Ashley OS, Marsden ME, Brady TM. Effectiveness of substance abuse treatment programming for women: a review. American Journal of Drug and Alcohol Abuse 2003;29(1):19-53.
17. Bolnick JM, Rayburn WF. Substance use disorders in women: special considerations during pregnancy. Obstetrics and Gynecology Clinics of North America 2003;30(3):545-58, vii.
18. Brady KT, Grice DE, Dustan L, Malcom R, Killeen T. Characteristics of pregnant cocaine abusers. NIDA Research Monograph 1993;132:114.
19. Brigham G, Winhusen T, Lewis D, Kropp F. Incentives for retention of pregnant substance users: a secondary analysis. Journal of Substance Abuse Treatment 2010;38(1):90-5.
20. Chang G, Carroll KM, Behr HM, Kosten TR. Improving treatment outcome in pregnant opiate-dependent women. Journal of Substance Abuse Treatment 1992;9(4):327-30.
21. Chang G, McNamara TK, Orav EJ, Koby D, Lavinge A, Ludman B, et al. Brief intervention for prenatal alcohol use: a randomized trial. Obstetrics and Gynecology 2005;105(5 Pt 1):991-8.
22. Chazotte C, Youchah J, Freda MC. Cocaine use during pregnancy and low birth weight: the impact of prenatal care and drug treatment. Seminars in Perinatology 1995;19(4):293-200.
23. Clark KA, Dee DL, Bale PL, Martin SL. Treatment compliance among prenatal care patients with substance abuse problems. American Journal of Drug and Alcohol Abuse 2001;27(1):121-36.
24. Daley M, Shepard DS, Bury-Maynard DB. Changes in quality of life for pregnant women in substance user treatment: developing a quality of life index for the addictions. Substance Use and Misuse 2005;40(3):375-94.
25. Day E, Porter L, Clarke A, Allen D, Moselhy H, Copello A. Drug misuse in pregnancy: the impact of a specialist treatment service. Psychiatric Bulletin 2003;27:99-101.
26. Drozdick J 3rd, Berghella V, Hill M, Kaltenbach K. Methadone trough levels in pregnancy. American Journal of Obstetrics and Gynecology 2002;187(5):1184-8.
27. Egelko S, Galanter M, Dermatis H, DeMaio C. Evaluation of a multisystems model for treating perinantal cocaine addiction. Journal of Substance Abuse Treatment 1998;15(3):251-9.
28. Elk R, Schmitz J, Spiga R, Rhoades H, Andres R, Grabowski J. Behavioral treatment of cocaine-dependent pregnant women and TB-exposed patients. Addictive Behaviors 1995;20(4):533-42.
29. Elk R, Mangus LG, LaSoya RJ, Rhoades HM, Andres RL, Grabowski J. Behavioral interventions: effective and adaptable for the treatment of pregnant cocaine-dependent women. Journal of Drug Issues 1997;27(3):625-58.
30. Erickson SJ, Tonigan JS, Bogenschulz MP. Therapist effects in the treatment of pregnant substance abusers: clinical trials network. Proceedings of the 70th Annual Scientific Meeting of the College on Problems of Drug Dependence; 2008 June 14-19; San Juan, Puerto Rico. http://www.cpdd.vcu.edu/Pages/Meetings/CPDD08AbstractBook2.pdf. 2008.
31. Finnegan LP, Amass L, Jones HE, Kaltenbach K. Addiction and pregnancy. Heroin Addiction and Related Clinical Problems 2005;7(4):5-22.
32. Fischer G, Jagsch R, Eder H, Gombas W, Etzersdorfer P, Schmidl-Mohl K, et al. Comparison of methadone and slow-release morphine maintenance in pregnant addicts. Addiction 1999;94(2):231-9.
33. Funai EF, White J, Lee MJ, Allen M, Kuczynski E. Compliance with prenatal care visits in substance abusers. Journal of Maternal-Fetal and Neonatal Medicine 2003;14(5):329-32.
34. Fundaro C, Genovese O, Baldieri F, Miccinesi N. Long-term neurodevelopmental outcome of children exposed to illicit substances during pregnancy: the role of home environmental factors. Italian Journal of Pediatrics 2004;30(2):118-24.
35. Greenfield SF, Rosa C, Putnins SI, Green CA, Brooks AJ, Calsyn DA, et al. Gender research in the National Institute on Drug Abuse National Treatment Clinical Trials Network: a summary of findings. American Journal of Drug and Alcohol Abuse 2011;37(5):301-12.
36. Hodnett ED, Fredericks S, Weston J. Support during pregnancy for women at increased risk of low birthweight babies (Review). Cochrane Collaboration 2010, (6).
37. Hulse G, O'Neil G. Using naltrexone implants in the management of the pregnant heroin user. Australian and New Zealand Journal of Obstetrics and Gynaecology 2002;42(5):569-73.
38. Jansson LM, Svikis DS, Beilenson P. Effectiveness of child case management services for offspring of drug-dependent women. Substance Use and Misuse 2003;38(14):1933-52.
39. Jones HE, Svikis DS, Tran G. Patient compliance and maternal/infant outcomes in pregnant drug-using women. Substance Use and Misuse 2002;37(11):1411-22.
40. Jones HE, Svikis D, Rosado J, Tuten M, Kulstad JL. What if they do not want treatment?: lessons learned from intervention studies of non-treatment-seeking, drug-using pregnant women. American Journal on Addictions 2004;13(4):342-57.
41. Jones HE, Tuten M, O'Grady KE. Treating the partners of opioid-dependent pregnant patients: feasibility and efficacy. American Journal of Drug and Alcohol Abuse 2011;37(3):170-8.
42. Kastner R, Hartl K, Lieber A, Hahlweg BC, Knobbe A, Grubert T, et al. Opiate addiction during pregnancy: Results of a psychosomatic treatment strategy with replacement therapy. Geburtshilfe und Frauenheilkunde 2002;32(1):32-6.
43. Kropp F, Winhusen T, Lewis D, Hague D, Somoza E. Increasing prenatal care and healthy behaviors in pregnant substance users. Journal of Psychoactive Drugs 2010;42(1):73-81.
44. Kukko H, Halmesmäki E. Prenatal care and counseling of female drug abusers: effects on drug abuse and perinatal outcome. Acta Obstetricia et Gynecologica Scandinavica 1999;78(1):22-6.
45. Nishimoto RH, Roberts AC. Coercion and drug treatment for postpartum women. American Journal of Drug and Alcohol Abuse 2001;27(1):161-81.
46. Ondersma SJ, Chase SK, Svikis D, Schuster CR. Computer-based brief motivational intervention for perinatal drug use. Journal of Substance Abuse Treatment 2005;28(4):305-12.
47. Ondersma SJ, Svikis DS, Schuster CR. Computer-based brief intervention. A randomized trial with postpartum women. American Journal of Preventive Medicine 2007;32(3):231-8.
48. Ondersma SJ, Winhusen T, Erickson SJ, Stine SM, Wang Y. Motivation Enhancement Therapy with pregnant substance-abusing women: does baseline motivation moderate efficacy?. Drug and Alcohol Dependence 2009;101(1-2):74-9.
49. Rayburn WF, Bogenschutz MP. Pharmacotherapy for pregnant women with addictions. American Journal of Obstetrics and Gynecology 2004;191(6):1885-97.
50. Roy J, Toubin R, Mazurier E, Chanal C, Misraoui M, Brulet C, et al. Developmental outcome of 5-year-old children born to opiate-dependent mothers: effects of a multidisciplinary intervention during pregnancy [Devenir a 5 ans des enfants de meres dependantes aux opiace's: effets d'un suivi multidisciplinaire pendant la grossesse]. Archives de Pediatrie 2011;18(11):1130-8.
51. Schottenfeld RS, Moore B, Pantalon MV. Contingency management with community reinforcement approach or twelve-step facilitation drug counseling for cocaine dependent pregnant women or women with young children. Drug and Alcohol Dependence 2011;118(1):48-55.
52. Seracini AM, Nunes E, Tross S, Spano C. Achieving cocaine abstinence in preinatal cocaine-dependent women: A contingency management approach. Problems of Drug Dependence 1996: Proceedings of the 58th Annual Scientific Meeting. Washington DC: NIH 97-4236, 1996:261.
53. Shieh C, Kravitz M. Maternal-fetal attachment in pregnant women who use illicit drugs. Journal of Obstetric, Gynecologic, and Neonatal Nursing 2002;31(2):156-64.
54. Svikis D, McCaul M, Feng T, Stuart M, Fox M, Stokes E. Drug dependence during pregnancy: Effect of an on-site support group. Journal of Reproductive Medicine 1998;43(9):799-805.
55. Sweeney PJ, Schwartz RM, Mattis NG, Vohr B. The effect of integrating substance abuse treatment with prenatal care on birth outcome. Journal of Perinatology 2000;20(4):219-24.
56. Tuten M, Jones HE. Reinforcement-based treatment is an effective treatment for drug dependence during pregnancy. Proceedings of the 68th Annual Scientific Meeting of the College on Problems of Drug Dependence; 2006; Orlando, Florida. 2006.
57. Tuten M, Fitzsimons H, Chisolm MS, Nuzzo PA, Jones HE. Contingent incentives reduce cigarette smoking among pregnant, methadone-maintained women: results of an initial feasibility and efficacy randomized clinical trial. Addiction 2012;107(10):1868-77.
58. Unger A, Jagsch R, Jones H, Arria A, Leitich H, Rohrmeister K, et al. Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison. Addiction 2011;106(7):1355-62.
59. Weisdorf T, Parran TV Jr, Graham A, Snyder C. Comparison of pregnancy-specific interventions to a traditional treatment program for cocaine-addicted pregnant women. Journal of Substance Abuse Treatment 1999;16(1):39-45.
60. Wexler HK, Cuadrado M, Stevens SJ. Residential treatment for women: behavioral and psychological outcomes. In: Stevens S, Wexler HK editor(s). Women and Substance Abuse. New York: Hawthorne Medical Press, 1998:213-33.
61. Whicher EV, Utku F, Schirmer G, Davis P, Abou-Saleh MT. Pilot project to evaluate the effectiveness and acceptability of single-session brief counseling for the prevention of substance misuse in pregnant adolescents. Addictive Disorders and their Treatment 2012;11(1):43-9.
62. Winhusen TM, Kropp F. Psychosocial treatments for women with substance use disorders. Obstetrics and Gynecology Clinics of North America 2003;30(3):483-99, vi.
63. Winklbaur-Hausknost B, Jagsch R, Graf-Rohrmeister K, Unger A, Baewert A, Langer M, et al. Lessons learned from a comparison of evidence-based research in pregnant opioid-dependent women. Human Psychopharmacology: Clinical and Experimental 2013;28(1):15-24.
64. Wong S, Ordean A, Kahan M. Substance use in pregnancy. International Journal of Gynecology & Obstetrics 2011;114(2):190-202.
65. Yonkers KA, Howell HB, Allen AE, Ball SA, Pantalon MV, Rounsaville BJ. A treatment for substance abusing pregnant women. Archives of Women's Mental Health 2009;12(4):221-7.
66. Zlotnick C, Franchino K, St Claire N, Cox K, St John M. The impact of outpatient drug services on abstinence among pregnant and parenting women. Journal of Substance Abuse Treatment 1996;13(3):195-202.
67. Australian Institute of Health and Welfare. National Drug Strategy Household Survey Report. Drug Statistics Series No. 25. www.aihw.gov.au (accessed 12/09/15).
68. Amato L, Minozzi S, Davoli M, Vecchi S. Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cochrane Database of Systematic Reviews 2011, Issue 10. [DOI: 10.1002/14651858.CD004147.pub4]
69. Amato L, Minozzi S, Pani PP, Solimini R, Vecchi S, Zuccaro P, et al. Dopamine agonists for the treatment of cocaine dependence. Cochrane Database of Systematic Reviews 2011, Issue 12. [DOI: 10.1002/14651858.CD003352.pub3]
70. Armstrong MA, Gonzales Osejo V, Lieberman L, Carpenter DM, Pantoja PM, Escobar GJ. Perinatal substance abuse intervention in obstetric clinics decreases adverse neonatal outcomes. Journal of Perinatology 2003;23(1):3-9.
71. Boyd SC. Mothers and Illicit Drugs: Transcending the Myths. Toronto: University of Toronto Press, 1999.
72. Dakof GA, Quille TJ, Tejeda MJ, Alberga LR, Bandstra E, Szapocznik J. Enrolling and retaining mothers of substance-exposed infants in drug abuse treatment. Journal of Consulting and Clinical Psychology 2003;71(4):764-72.
73. Daley M, Argeriou M, McCarty D. Substance abuse treatment for pregnant women: a window of opportunity?. Addictive Behaviors 1998;23(2):239-49.
74. DiClemente CC, Prochaska JO. Towards a comprehensive, trans theoretical model of change: Stages of change and addictive behaviours. In: Miller WR, Heather N editor(s). Treating Addictive Behaviours. 2. New York: Plenum Press, 1998:3-24.
75. Frank DA, Augustyn M, Knight WG, Pell T, Zuckerman B. Growth, development, and behavior in early childhood following prenatal cocaine exposure: a systematic review. JAMA 2001;285(12):1613-25.
76. Cochrane Collaboration. GRADEPro. Cochrane Collaboration, 2014.
77. Grella CE, Joshi V, Hser YI. Program variation in treatment outcomes among women in residential drug treatment. Evaluation Reviews 2000;24(4):364-83.
78. Grimes DA, Schulz KF. Surrogate end points in clinical research: hazardous to your health. Obstetrics and Gynecology 2005;105(5 Pt 1):1114-8.
79. Hettema J, Steele J, Miller WR. Motivational interviewing. Annual Review of Clinical Psychology 2005;1:91-111.
80. Higgins ST, Delaney DD, Budney AJ, Bickel WK, Hughes JR, Foerg F, et al. A behavioral approach to achieving initial cocaine abstinence. American Journal of Psychiatry 1991;148(9):1218-24.
81. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available at www.cochrane-handbook.org.
82. Howell EM, Heiser N, Cherlow A, Mason M, Ewell D, Potwein S. Identifying pregnant substance abusers and studying their treatment using birth certificates, Medicaid claims, and state substance abuse treatment data. NIDA Research Monograph 2000;1:225-41.
83. Hser YI, Maglione M, Polinsky ML, Anglin MD. Predicting drug treatment entry among treatment-seeking individuals. Journal of Substance Abuse Treatment 1998;15(3):213-20.
84. Hubbard RL, Mardsen ME, Rachal JV, Harwood HJ, Cavanaugh ER, Ginzburg HM. Drug Abuse Treatment: A national study of effectiveness. Chapel Hill: University of North Carolina Press, 1989.
85. Kuczkowski KM. The effects of drug abuse on pregnancy. Obstetrics and Gynecology 2007;19(6):578-85.
86. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
87. Ludlow JP, Evans SF, Hulse G. Obstetric and perinatal outcomes in pregnancies associated with illicit substance abuse. Australian and New Zealand Journal of Obstetrics & Gynaecology 2004;44(4):302-6.
88. McCaul ME, Svikis DS. Service utilization measures in drug treatment research. In: Rahdert E editor(s). Treatment for D Exposed Women and Their Children: Advances in Research Methodology. Washington DC: U.S. Government Printing Office, 1996:225-41.
89. Miller WR. Motivational enhancement therapy manual: A clinical research guide for therapists treating individuals with alcohol abuse and dependence. National Institute on Alcohol Abuse and Alcoholism 1995;2.
90. Miller WR, Yahne CE, Tonigan JS. Motivational interviewing in drug abuse services: a randomized trial. Journal of Consulting and Clinical Psychology 2003;71(4):754-63.
91. Murphy S, Rosenbaum M. Pregnant Women on Drugs: Combating Stereotypes and Stigma. New Brunswick: Rutgers University Press, 1999.
92. Cochrane Collaboration. Review Manager 5.3. RevMan 2014. Cochrane Collaboration, 2014.
93. Rollnick S, Miller WR. What is Motivational Interviewing?. Behavioural and Cognitive Psychotherapy 1995;23:325-34.
94. Sherwood RA, Keating J, Kavvadia V, Greenough A, Peters TJ. Substance misuse in early pregnancy and relationship to fetal outcome. European Journal of Pediatrics 1999;158(6):488-92.
95. Signorini DF, Leung O, Simes RJ, Beller E, Gebski VJ, Callaghan T. Dynamic balanced randomization for clinical trials. Statistics in Medicine 1993;12(24):2343-50.
96. Singer LT, Minnes S, Short E, Arendt R, Farkas K, Lewis B, et al. Cognitive outcomes of preschool children with prenatal cocaine exposure. JAMA 2004;291(20):2448-56.
97. Sitzer M, Petry N. Contingency management for treatment of substance abuse. Annual Review of Clinical Psychology 2006;2:411-34.
98. Skinner BF. Superstition in the Pidgeon. Journal of Experimental Psychology 1947;38:168-72.
99. Terplan M, Smith EJ, Kozloski MJ, Pollack HA. "Compassionate coercion": factors associated with court-mandated drug and alcohol treatment in pregnancy 1994-2005. Journal of Addiction Medicine 2010;4(3):147-52.
100. Thorndike EL. Animal intelligence: An experimental study of the associative processes in animals. Psychological Review Monograph Supplement 1898;2(4):109.
101. Terplan M, Lui S. Psychosocial interventions for pregnant women in outpatient illicit drug treatment programs compared to other interventions. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD006037.pub2]